MYBPC3 and hypertrophic cardiomyopathy: Additional studies are needed to understand the role of MyBP-C content in the modulation of thick filament protein degradation in vivo to gain insight into the complex role of proteostasis in diseases such as hypertrophic cardiomyopathy.